References
- NieSXingYKimGJSimonsJWNanotechnology applications in cancerAnnu Rev Biomed Eng2007925728817439359
- NiemeyerCMSemi-synthetic nucleic acid-protein conjugates: applications in life sciences and nanobiotechnologyJ Biotechnol2001821476611999713
- NishiyamaNNanomedicine: nanocarriers shape up for long lifeNat Nanotechnol20072420320418654260
- FerrariMCancer nanotechnology: opportunities and challengesNat Rev Cancer20055316117115738981
- CuencaAGJiangHHochwaldSNDelanoMCanceWGGrobmyerSREmerging implications of nanotechnology on cancer diagnostics and therapeuticsCancer2006107345946616795065
- WangXYangLChenZGShinDMApplication of nanotechnology in cancer therapy and imagingCA Cancer J Clin20085829711018227410
- McNeilSENanoparticle therapeutics: a personal perspectiveWiley Interdiscip Rev Nanomed Nanobiotechnol20091326427120049796
- FreitasRAJrWhat is nanomedicine?Nanomedicine2005112917292052
- FreitasRAJrCurrent status of nanomedicine and medical nanoroboticsJ Comput Theor Nanos200521125
- TorchilinVAntibody-modified liposomes for cancer chemotherapyExpert Opin Drug Deliv2008591003102518754750
- VasirJKLabhasetwarVBiodegradable nanoparticles for cytosolic delivery of therapeuticsAdv Drug Deliv Rev200759871872817683826
- SahooSKLabhasetwarVNanotech approaches to drug delivery and imagingDrug Discov Today20038241112112014678737
- BarretoJAO’MalleyWKubeilMGrahamBStephanHSpicciaLNanomaterials: applications in cancer imaging and therapyAdv Mater20112312H184021433100
- JudsonIRadfordJAHarrisMRandomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma GroupEur J Cancer200137787087711313175
- HubertALyassOPodeDGabizonADoxil (Caelyx): an exploratory study with pharmacokinetics in patients with hormone-refractory prostate cancerAnticancer Drugs200011212312710789595
- ForssenEAMale-BruneRAdler-MooreJPFluorescence imaging studies for the disposition of daunorubicin liposomes (DaunoXome) within tumor tissueCancer Res1996569206620758616852
- GuaglianonePChanKDelaFlor-WeissEPhase I and pharmacologic study of liposomal daunorubicin (DaunoXome)Invest New Drugs19941221031107860226
- JaeckleKABatchelorTO’DaySJAn open label trial of sustained- release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitisJ Neurooncol200257323123912125986
- GlantzMJJaeckleKAChamberlainMCA randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumorsClin Cancer Res19995113394340210589750
- Vincristine liposomal – INEX: lipid-encapsulated vincristine, Onco TCS, transmembrane carrier system – vincristine, vincacine, vincristine sulfate liposomes for injection, VSLIDrugs R D20045211912315293876
- FassasAAnagnostopoulosAThe use of liposomal daunorubicin (DaunoXome) in acute myeloid leukemiaLeuk Lymphoma200546679580216019523
- CharroisGJAllenTMDrug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancerBiochim Biophys Acta200416631–216717715157619
- SimoesSMoreiraJNFonsecaCDuzgunesNde LimaMCOn the formulation of pH-sensitive liposomes with long circulation timesAdv Drug Deliv Rev200456794796515066754
- LeamonCPCooperSRHardeeGEFolate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivoBioconjug Chem200314473874712862426
- OriveGGasconARHernandezRMDominguez-GilAPedrazJLTechniques: new approaches to the delivery of biopharmaceuticalsTrends Pharmacol Sci200425738238715219981
- SlingerlandMGuchelaarHJGelderblomHLiposomal drug formulations in cancer therapy: 15 years along the roadDrug Discov Today9292011 [Epub ahead of print.]
- ChanAShihVTham CheeKLiposomal doxorubicin-associated acute hypersensitivity despite appropriate preventive measuresJ Oncol Pharm Pract200713210510717873110
- SzebeniJComplement activation-related pseudoallergy caused by amphiphilic drug carriers: the role of lipoproteinsCurr Drug Deliv20052444344916305447
- VealGJGriffinMJPriceEA phase I study in paediatric patients to evaluate the safety and pharmacokinetics of SPI-77, a liposome encapsulated formulation of cisplatinBr J Cancer20018481029103511308249
- WhiteSCLoriganPMargisonGPPhase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancerBr J Cancer200695782282816969346
- SteeleJPO’DohertyCAShamashJPhase II trial of liposomal daunorubicin in malignant pleural mesotheliomaAnn Oncol200112449749911398882
- XingYSmithAMAgrawalARuanGNieSMolecular profiling of single cancer cells and clinical tissue specimens with semiconductor quantum dotsInt J Nanomedicine20061447348117722280
- SeydelCQuantum dots get wetScience20033005616808112677056
- BruchezMJrMoronneMGinPWeissSAlivisatosAPSemiconductor nanocrystals as fluorescent biological labelsScience19982815385201320169748157
- PinaudFMichaletXBentolilaLAAdvances in fluorescence imaging with quantum dot bio-probesBiomaterials20062791679168716318871
- GaoXYangLPetrosJAMarshallFFSimonsJWNieSIn vivo molecular and cellular imaging with quantum dotsCurr Opin Biotechnol2005161637215722017
- MichaletXPinaudFFBentolilaLAQuantum dots for live cells, in vivo imaging, and diagnosticsScience2005307570953854415681376
- AlivisatosPThe use of nanocrystals in biological detectionNat Biotechnol2004221475214704706
- ShioharaAHoshinoAHanakiKSuzukiKYamamotoKOn the cyto-toxicity caused by quantum dotsMicrobiol Immunol200448966967515383704
- LovricJBazziHSCuieYFortinGRWinnikFMMaysingerDDifferences in subcellular distribution and toxicity of green and red emitting CdTe quantum dotsJ Mol Med (Berl)200583537738515688234
- HoshinoAManabeNFujiokaKSuzukiKYasuharaMYamamotoKUse of fluorescent quantum dot bioconjugates for cellular imaging of immune cells, cell organelle labeling, and nanomedicine: surface modification regulates biological function, including cytotoxicityJ Artif Organs200710314915717846713
- ChoiAOChoSJDesbaratsJLovricJMaysingerDQuantum dot- induced cell death involves Fas upregulation and lipid peroxidation in human neuroblastoma cellsJ Nanobiotechnol200751
- GaoXChungLWNieSQuantum dots for in vivo molecular and cellular imagingMethods Mol Biol200737413514517237536
- SmithAMRuanGRhynerMNNieSEngineering luminescent quantum dots for in vivo molecular and cellular imagingAnn Biomed Eng200634131416450199
- DubertretBSkouridesPNorrisDJNoireauxVBrivanlouAHLibchaberAIn vivo imaging of quantum dots encapsulated in phospholipid micellesScience200229855991759176212459582
- RawatMSinghDSarafSNanocarriers: promising vehicle for bioactive drugsBiol Pharm Bull20062991790179816946487
- HamaguchiTMatsumuraYSuzukiMNK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxelBr J Cancer20059271240124615785749
- LavasanifarASamuelJKwonGSPoly(ethylene oxide)-block-poly(L-amino acid) micelles for drug deliveryAdv Drug Deliv Rev200254216919011897144
- BaeYNishiyamaNFukushimaSKoyamaHYasuhiroMKataokaKPreparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacyBioconjug Chem200516112213015656583
- NakanishiTFukushimaSOkamotoKDevelopment of the polymer micelle carrier system for doxorubicinJ Control Release2001741–329530211489509
- TorchilinVPLukyanovANGaoZPapahadjopoulos-SternbergBImmunomicelles: targeted pharmaceutical carriers for poorly soluble drugsProc Natl Acad Sci U S A2003100106039604412716967
- MohantyCAcharyaSMohantyAKDilnawazFSahooSKCurcumin- encapsulated MePEG/PCL diblock copolymeric micelles: a novel controlled delivery vehicle for cancer therapyNanomedicine (Lond)20105343344920394536
- WuGDatarRHHansenKMThundatTCoteRJMajumdarABioassay of prostate-specific antigen (PSA) using microcantileversNat Biotechnol200119985686011533645
- TekadeRKKumarPVJainNKDendrimers in oncology: an expanding horizonChem Rev20091091498719099452
- SvensonSTomaliaDADendrimers in biomedical applications – reflections on the fieldAdv Drug Deliv Rev200557152106212916305813
- TomaliaDASupramolecular chemistry: fluorine makes a differenceNat Mater200321171171214593393
- ChoiYThomasTKotlyarAIslamMTBakerJRJrSynthesis and functional evaluation of DNA-assembled polyamidoamine dendrimer clusters for cancer cell-specific targetingChem Biol2005121354315664513
- XuHReginoCAKoyamaYPreparation and preliminary evaluation of a biotin-targeted, lectin-targeted dendrimer-based probe for dual-modality magnetic resonance and fluorescence imagingBioconjug Chem20071851474148217711320
- KobayashiHBrechbielMWDendrimer-based macromolecular MRI contrast agents: characteristics and applicationMol Imaging20032111012926232
- JiangYHEmauPCairnsJSSPL7013 gel as a topical microbicide for prevention of vaginal transmission of SHIV89.6P in macaquesAIDS Res Hum Retroviruses200521320721315795526
- GrodzinskiPSilverMMolnarLKNanotechnology for cancer diagnostics: promises and challengesExpert Rev Mol Diagn20066330731816706735
- NuneSKGundaPThallapallyPKLinYYForrestMLBerklandCJNanoparticles for biomedical imagingExpert Opin Drug Deliv20096111175119419743894
- BiancoAKostarelosKPartidosCDPratoMBiomedical applications of functionalised carbon nanotubesChem Commun (Camb)2005557157715672140
- BachiloSMStranoMSKittrellCHaugeRHSmalleyREWeismanRBStructure-assigned optical spectra of single-walled carbon nanotubesScience200229856022361236612459549
- PastorinGWuWWieckowskiSDouble functionalization of carbon nanotubes for multimodal drug deliveryChem Commun (Camb)2006111182118416518484
- RadomskiAJuraszPAlonso-EscolanoDNanoparticle-induced platelet aggregation and vascular thrombosisBr J Pharmacol2005146688289316158070
- WarheitDBLaurenceBRReedKLRoachDHReynoldsGAWebbTRComparative pulmonary toxicity assessment of single-wall carbon nanotubes in ratsToxicol Sci200477111712514514968
- MullerJHuauxFMoreauNRespiratory toxicity of multi-wall carbon nanotubesToxicol Appl Pharmacol2005207322123116129115
- De JongWHBormPJDrug delivery and nanoparticles: applications and hazardsInt J Nanomedicine20083213314918686775
- YinJJLaoFMengJInhibition of tumor growth by endohedral metallofullerenol nanoparticles optimized as reactive oxygen species scavengerMol Pharmacol20087441132114018635669
- MisraRAcharyaSSahooSKCancer nanotechnology: application of nanotechnology in cancer therapyDrug Discov Today20101519–2084285020727417
- GrefRMinamitakeYPeracchiaMTTrubetskoyVTorchilinVLangerRBiodegradable long-circulating polymeric nanospheresScience19942635153160016038128245
- PortneyNGOzkanMNano-oncology: drug delivery, imaging, and sensingAnal Bioanal Chem2006384362063016440195
- PeerDKarpJMHongSFarokhzadOCMargalitRLangerRNanocarriers as an emerging platform for cancer therapyNat Nanotechnol200721275176018654426
- KawasakiESPlayerANanotechnology, nanomedicine, and the development of new, effective therapies for cancerNanomedicine20051210110917292064
- GrefRDombAQuellecPThe controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheresAdv Drug Deliv Rev1995162–3215233
- DengCTianHZhangPSunJChenXJingXSynthesis and characterization of RGD peptide grafted poly(ethylene glycol)- b-poly(L-lactide)-b-poly(L-glutamic acid) triblock copolymerBiomacromolecules20067259059616471935
- MosqueiraVCLegrandPMorgatJLBiodistribution of long-circulating PEG-grafted nanocapsules in mice: effects of PEG chain length and densityPharm Res200118101411141911697466
- StolnikSDunnSEGarnettMCSurface modification of poly(lactide-co- glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymersPharm Res19941112180018087899246
- SiddiquiIAAdhamiVMBharaliDJIntroducing nanochemo-prevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallateCancer Res20096951712171619223530
- ShutavaTGBalkundiSSVangalaPLayer-by-layer-coated gelatin nanoparticles as a vehicle for delivery of natural polyphenolsACS Nano2009371877188519534472
- ShutavaTGBalkundiSSLvovYM(−)-Epigallocatechin gallate/gelatin layer-by-layer assembled films and microcapsulesJ Colloid Interface Sci2009330227628319027120
- BarrasAMezzettiARichardAFormulation and characterization of polyphenol-loaded lipid nanocapsulesInt J Pharm2009379227027719501139
- ZuYGYuanSZhaoXHZhangYZhangXNJiangRPreparation, activity and targeting ability evaluation in vitro on folate mediated epigallocatechin-3-gallate albumin nanoparticlesYao Xue Xue Bao2009445525531 Chinese19618731
- DubeANicolazzoJALarsonIChitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (−)-epigallocatechin gallateEur J Pharm Sci201041221922520600878
- HanDWLeeJJJungDYParkJCHyonSHDevelopment of epigallocatechin gallate-eluting polymeric stent and its physicochemical, biomechanical and biological evaluationsBiomed Mater20094444104
- ItaliaJLDattaPAnkolaDDKumarMNVRNanoparticles enhance per oral bioavailability of poorly available molecules: epigallocatechin gallate nanoparticles ameliorates cyclosporine induced nephrotoxicity in rats at three times lower dose than oral solutionJ Biomed Nanotechnol20084304312
- RochaSGeneralovRdo PereiraMCPeresIJuzenasPCoelhoMAEpigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemopreventionNanomedicine (Lond)201161798721182420
- SinghMBhatnagarPSrivastavaAKKumarPShuklaYGuptaKCEnhancement of cancer chemosensitization potential of cisplatin by tea polyphenols poly(lactide-co-glycolide) nanoparticlesJ Biomed Nanotechnol20117120221485870
- HsiehDSWangHTanSWThe treatment of bladder cancer in a mouse model by epigallocatechin-3-gallate-gold nanoparticlesBiomaterials201132307633764021782236
- AzizMHReagan-ShawSWuJLongleyBJAhmadNChemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease?FASEB J20051991193119515837718
- AzizMHKumarRAhmadNCancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review)Int J Oncol2003231172812792772
- BhatKPPezzutoJMCancer chemopreventive activity of resveratrolAnn N Y Acad Sci200295721022912074974
- YaoQHouSXHeWLStudy on the preparation of resveratrol chitosan nanoparticles with free amino groups on the surfaceZhongguo Zhong Yao Za Zhi2006313205208 Chinese16572999
- ShaoJLiXLuXEnhanced growth inhibition effect of resveratrol incorporated into biodegradable nanoparticles against glioma cells is mediated by the induction of intracellular reactive oxygen species levelsColloids Surf B Biointerfaces2009721404719395246
- LuXJiCXuHResveratrol-loaded polymeric micelles protect cells from Abeta-induced oxidative stressInt J Pharm20093751–2899619481694
- NarayananNKNargiDRandolphCNarayananBALiposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout miceInt J Cancer200912511819326431
- KobierskiSOfori-KwakyeKMullerRHKeckCMResveratrol nanosuspensions for dermal application – production, characterization, and physical stabilityPharmazie2009641174174720099519
- TeskacKKristlJThe evidence for solid lipid nanoparticles mediated cell uptake of resveratrolInt J Pharm20103901616919833178
- YadavVRAggarwalBBCurcumin: A component of the golden spice, targets multiple angiogenic pathwaysCancer Biol Ther201111223624121191188
- TonnesenHHSolubility, chemical and photochemical stability of curcumin in surfactant solutions. Studies of curcumin and curcuminoids, XXVIIIPharmazie2002571282082412561244
- TiyaboonchaiWTungpraditWPlianbangchangPFormulation and characterization of curcuminoids loaded solid lipid nanoparticlesInt J Pharm20073371–229930617287099
- BishtSFeldmannGSoniSRaviRKarikarCMaitraAPolymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): a novel strategy for human cancer therapyJ Nanobiotechnology20075317439648
- SahuABoraUKasojuNGoswamiPSynthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cellsActa Biomater2008461752176118524701
- ThangapazhamRLPuriATeleSBlumenthalRMaheshwariRKEvaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cellsInt J Oncol20083251119112318425340
- DasRKKasojuNBoraUEncapsulation of curcumin in alginate-chitosan- pluronic composite nanoparticles for delivery to cancer cellsNanomedicine20106115316019616123
- MerrellJGMcLaughlinSWTieLLaurencinCTChenAFNairLSCurcumin loaded poly(epsilon-caprolactone) nanofibers: diabetic wound dressing with antioxidant and anti-inflammatory propertiesClin Exp Pharmacol Physiol200936121149115619473187
- LiJWangYYangCPolyethylene glycosylated curcumin conjugate inhibits pancreatic cancer cell growth through inactivation of Jab1Mol Pharmacol2009761819019395473
- ShaikhJAnkolaDDBeniwalVSinghDKumarMNNanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancerEur J Pharm Sci2009373–422323019491009
- DasRKKasojuNBoraUEncapsulation of curcumin in alginatechitosan- pluronic composite nanoparticles for delivery to cancer cellsNanomedicine20106115316019616123
- AnandPNairHBSungBDesign of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivoBiochem Pharmacol201079333033819735646
- MukerjeeAVishwanathaJKFormulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapyAnticancer Res200929103867387519846921
- OnoueSTakahashiHKawabataYFormulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailabilityJ Pharm Sci20109941871188119827133
- SouKOyajobiBGoinsBPhillipsWTTsuchidaECharacterization and cytotoxicity of self-organized assemblies of curcumin and amphiphatic poly(ethylene glycol)J Biomed Nanotechnol20095220220820055098
- PrajaktaDRatneshJChandanKCurcumin loaded pH-sensitive nanoparticles for the treatment of colon cancerJ Biomed Nanotechnol20095544545520201417
- YallapuMMGuptaBKJaggiMChauhanSCFabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cellsJ Colloid Interface Sci20103511192920627257
- YallapuMMMaherDMSundramVBellMCJaggiMChauhanSCCurcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growthJ Ovarian Res201031120429876
- RozziANardoniCCoronaMRestucciaMRFalboTLanzettaGWeekly regimen of paclitaxel and carboplatin as first-line chemotherapy in elderly patients with stage IIIB-IV non small cell lung cancer (NSCLC): results of a Phase II studyJ Chemother201122641942321303751
- GuptaSCKimJHPrasadSAggarwalBBRegulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticalsCancer Metastasis Rev201029340543420737283
- WuYYChangJYChaoTYPaclitaxel and carboplatin-induced complete remission in peritoneal carcinomatosis of unknown origin: a report of two cases and review of the literatureTumori201096233633920572596
- GeorgeJBanikNLRaySKCombination of taxol and Bcl-2 siRNA induces apoptosis in human glioblastoma cells and inhibits invasion, angiogenesis and tumour growthJ Cell Mol Med200913104205421819473291
- FonsecaCSimoesSGasparRPaclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activityJ Control Release200283227328612363453
- FengSSMuLWinKYHuangGNanoparticles of biodegradable polymers for clinical administration of paclitaxelCurr Med Chem200411441342414965222
- OnyukselHJeonERubinsteinINanomicellar paclitaxel increases cytotoxicity of multidrug resistant breast cancer cellsCancer Lett2009274232733019022562
- SahooSKMaWLabhasetwarVEfficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancerInt J Cancer2004112233534015352049
- VanSDasSKWangXSynthesis, characterization, and biological evaluation of poly(L-gamma-glutamyl-glutamine)- paclitaxel nanoconjugateInt J Nanomedicine2010582583721042550
- LeeALWangYPervaizSFanWYangYYSynergistic anticancer effects achieved by co-delivery of TRAIL and paclitaxel using cationic polymeric micellesMacromol Biosci2011112296230721154473
- BharaliDJKhalilMGurbuzMSimoneTMMousaSANanoparticles and cancer therapy: a concise review with emphasis on dendrimersInt J Nanomedicine2009411719421366
- BharaliDJLuceyDWJayakumarHPudavarHEPrasadPNFolate- receptor-mediated delivery of InP quantum dots for bioimaging using confocal and two-photon microscopyJ Am Chem Soc200512732113641137116089466
- ChatterjeeDKFongLSZhangYNanoparticles in photodynamic therapy: an emerging paradigmAdv Drug Deliv Rev200860151627163718930086
- FarokhzadOCChengJTeplyBATargeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivoProc Natl Acad Sci U S A2006103166315632016606824
- FarokhzadOCLangerRImpact of nanotechnology on drug deliveryACS Nano200931162019206243
- ZhangLGuFXChanJMWangAZLangerRSFarokhzadOCNanoparticles in medicine: therapeutic applications and developmentsClin Pharmacol Ther200883576176917957183
- BlagosklonnyMVHow cancer could be cured by 2015Cell Cycle20054226927815655345